Universität zu Köln

Schiza, Sophia, Simonds, Anita, Randerath, Winfried ORCID: 0000-0002-5010-8461, Fanfulla, Francesco ORCID: 0000-0002-8601-423X, Testelmans, Dries ORCID: 0000-0001-7303-9799, Grote, Ludger, Montserrat, Joseph M., Pepin, Jean-Louis, Verbraecken, Johan, Ersu, Refika and Bonsignore, Maria R. (2021). Sleep laboratories reopening and COVID-19: a European perspective. Eur. Resp. J., 57 (3). SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. ISSN 1399-3003

Full text not available from this repository.

Abstract

Clinical activities regarding sleep disordered breathing (SDB) have been sharply interrupted during the initial phase of the coronavirus disease 2019 (COVID-19) epidemic throughout Europe. In the past months, activities have gradually restarted, according to epidemiological phase of COVID-19 and national recommendations. The recent increase in cases throughout Europe demands a reconsideration of management strategies of SDB accordingly. Diagnosis of SDB and initiation of treatment pose some specific problems to be addressed to preserve the safety of patients and health personnel. This perspective document by a group of European sleep experts aims to summarise some different approaches followed in Europe and United States, which reflect national recommendations according to the epidemiological phase of the COVID-19 infection. Respiratory sleep medicine is likely to change in the near future, and use of telemedicine will grow to avoid unnecessary risks and continue to provide optimal care to patients. In addition, the document covers paediatric sleep studies and indications for titration of noninvasive ventilation, as well as precautions to be followed by patients who are already on positive airway pressure treatment. A single consensus document developed by the European Respiratory Society and national societies would be desirable to harmonise SDB management throughout Europe. Clinical activities regarding sleep disordered breathing (SDB) have been sharply interrupted during the initial phase of the coronavirus disease 2019 (COVID-19) epidemic throughout Europe. In the past months, activities have gradually restarted, according to epidemiological phase of COVID-19 and national recommendations. The recent increase in cases throughout Europe demands a reconsideration of management strategies of SDB accordingly. Diagnosis of SDB and initiation of treatment pose some specific problems to be addressed to preserve the safety of patients and health personnel. This perspective

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Schiza, Sophia UNSPECIFIED UNSPECIFIED UNSPECIFIED Simonds, Anita UNSPECIFIED UNSPECIFIED UNSPECIFIED Randerath, Winfried UNSPECIFIED orcid.org/0000-0002-5010-8461 UNSPECIFIED Fanfulla, Francesco UNSPECIFIED orcid.org/0000-0002-8601-423X UNSPECIFIED Testelmans, Dries UNSPECIFIED orcid.org/0000-0001-7303-9799 UNSPECIFIED Grote, Ludger UNSPECIFIED UNSPECIFIED UNSPECIFIED Montserrat, Joseph M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Pepin, Jean-Louis UNSPECIFIED UNSPECIFIED UNSPECIFIED Verbraecken, Johan UNSPECIFIED UNSPECIFIED UNSPECIFIED Ersu, Refika UNSPECIFIED UNSPECIFIED UNSPECIFIED Bonsignore, Maria R. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-604795
DOI:	10.1183/13993003.02722-2020
Journal or Publication Title:	Eur. Resp. J.
Volume:	57
Number:	3
Date:	2021
Publisher:	EUROPEAN RESPIRATORY SOC JOURNALS LTD
Place of Publication:	SHEFFIELD
ISSN:	1399-3003
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language APNEA; DIAGNOSIS; MANAGEMENT; HOME Multiple languages Respiratory System Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/60479